Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8996397 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL18222653 | 0.95 | ALDH1A1 (0.54) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL17526930 | 0.95 | ALDH1A1 (0.43) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL9156073 | 0.95 | ALDH1A1 (0.43) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL1433752 | 0.95 | LMNA (0.48) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL6440409 | 0.95 | ALDH1A1 (0.54) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL6445562 | 0.92 | LMNA (0.58) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL6440890 | 0.92 | LMNA (0.50) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL1099125 | 0.92 | LMNA (0.50) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL3097319 | 0.90 | LMNA (0.62) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735417-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | Shanghai Vitalgen Biopharma Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-20250375392-A1 | Branched Tail Lipids and Uses Thereof | UNIV CARNEGIE MELLON (US) | 2025-12-11 | — | — | US | disclosed |
| WO-2025002399-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | SHANGHAI VITALGEN BIOPHARMA CO., LTD. (CN) | 2025-01-02 | — | — | WO | disclosed |
| WO-2025000542-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | SHANGHAI VITALGEN BIOPHARMA CO., LTD. (CN) | 2025-01-02 | — | — | WO | disclosed |
| CN-117683220-A | Preparation method of hydrophilic plasticized polyvinyl chloride plastic | 北京化工大学 | 2024-03-12 | — | — | CN | disclosed |
| US-11384056-B2 | Method for the manufacturing of delmopinol intermediates | LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) | 2022-07-12 | — | — | US | disclosed |
| EP-3558952-B1 | METHOD FOR THE MANUFACTURING OF DELMOPINOL AND OF ITS INTERMEDIATES | LUNDBECK PHARMACEUTICALS ITALY S P A (IT) | 2022-02-09 | — | — | EP | disclosed |
| US-20210130307-A1 | METHOD FOR THE MANUFACTURING OF DELMOPINOL INTERMEDIATES | LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) | 2021-05-06 | — | — | US | disclosed |
| EP-3558951-B1 | METHOD FOR THE MANUFACTURING OF DELMOPINOL | LUNDBECK PHARMACEUTICALS ITALY S P A (IT) | 2021-04-14 | — | — | EP | disclosed |
| US-10894778-B2 | Method for the manufacturing of delmopinol | LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) | 2021-01-19 | — | — | US | disclosed |
| US-7902357-B2 | Process for the preparation of delmopinol and derivatives thereof | SINCLAIR PHARMACEUTICALS LIMITED (GB) | 2011-03-08 | — | — | US | disclosed |
| US-20110001221-A1 | DIELECTRIC LAYER | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2011-01-06 | — | — | US | disclosed |
| US-7829137-B2 | Fabricating dielectric layer | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-11-09 | — | — | US | disclosed |
| US-20100222579-A1 | Process for the Preparation of Delmopinol and Derivatives Thereof | ARTUS SURROCA JUAN JOSE | 2010-09-02 | — | — | US | disclosed |
| US-20100222579-A1 | Process for the Preparation of Delmopinol and Derivatives Thereof | ARTUS SURROCA JUAN JOSE | 2010-09-02 | — | — | US | disclosed |
| US-20090137798-A1 | Process for the Preparation of Delmopinol and Derivatives Thereof | SINCLAIR PHARMACEUTICALS LIMITED (GB) | 2009-05-28 | — | — | US | disclosed |
| US-20090137798-A1 | Process for the Preparation of Delmopinol and Derivatives Thereof | SINCLAIR PHARMACEUTICALS LIMITED (GB) | 2009-05-28 | — | — | US | disclosed |
| US-20070172583-A1 | DIELECTRIC LAYER, COMPOSITION AND METHOD FOR FORMING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2007-07-26 | — | — | US | disclosed |
| US-6888030-B2 | Advances in amination | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2005-05-03 | — | — | US | disclosed |
| US-20030078344-A1 | Advances in amination | HUNTSMAN PETROCHEMICAL CORPORATION | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894778-B2 | Method for the manufacturing of delmopinol | THOP1, IGF2BP2, IGF2BP3 | ALDH1A1 2513/4885LMNA 2063/4885SMN1; SMN2 2025/4885 |
| US-20100222579-A1 | Process for the Preparation of Delmopinol and Derivatives Thereof | MDN1, MCOLN3, EML4 | ALDH1A1 2327/4885LMNA 1976/4885SMN1; SMN2 2100/4885 |
| US-20090137798-A1 | Process for the Preparation of Delmopinol and Derivatives Thereof | MDN1, MCOLN3, EML4 | ALDH1A1 2353/4885LMNA 2019/4885SMN1; SMN2 2106/4885 |
| US-20210130307-A1 | METHOD FOR THE MANUFACTURING OF DELMOPINOL INTERMEDIATES | THOP1, PTMS, NISCH | ALDH1A1 1535/4885LMNA 3176/4885SMN1; SMN2 2940/4885 |
| US-11384056-B2 | Method for the manufacturing of delmopinol intermediates | THOP1, PTMS, CYP4A11 | ALDH1A1 1443/4885LMNA 3142/4885SMN1; SMN2 2918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.